找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cardiovascular Biomarkers; Pathophysiology and David A. Morrow Book 2006 Humana Press 2006 cardiovascular.heart.heart disease.myocardial i

[复制链接]
查看: 16418|回复: 60
发表于 2025-3-21 17:28:48 | 显示全部楼层 |阅读模式
书目名称Cardiovascular Biomarkers
副标题Pathophysiology and
编辑David A. Morrow
视频video
概述Includes supplementary material:
丛书名称Contemporary Cardiology
图书封面Titlebook: Cardiovascular Biomarkers; Pathophysiology and  David A. Morrow Book 2006 Humana Press 2006 cardiovascular.heart.heart disease.myocardial i
描述In the four pages committed to a discussion of myocardial infarction in the first edition of Harrison’s Principles of Internal Medicine, published in 1950, there was no mention of use of the laboratory for management of patients. Thirty years later, when the first edition of Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine was published, 2 out of the 1943 pages in the text contained a discussion of the laboratory examinations in acute myocardial infarction. Our knowledge base of the multitude of ways that physicians can and should use the clinical chemistry laboratory has expanded dramatically since these classic texts were published. The nomenclature has changed: terms such as “cardiac enzymes” have given way to “cardiac biomarkers. ” The number of assays has multiplied, and the operating characteristics of available assays are impr- ing at a gratifying but dizzying rate. We now use biomarkers to diagnose cardiovascular diseases and also to frame our treatment strategies. Thus, there is a clear need for a scholarly compilation of the state of the art of cardiac biomarkers. Dr. David Morrow has expertly edited an authoritative book that answers this need. The 34 cha
出版日期Book 2006
关键词cardiovascular; heart; heart disease; myocardial infarction; physiology; vascular disease
版次1
doihttps://doi.org/10.1007/978-1-59745-051-5
isbn_softcover978-1-61737-620-7
isbn_ebook978-1-59745-051-5Series ISSN 2196-8969 Series E-ISSN 2196-8977
issn_series 2196-8969
copyrightHumana Press 2006
The information of publication is updating

书目名称Cardiovascular Biomarkers影响因子(影响力)




书目名称Cardiovascular Biomarkers影响因子(影响力)学科排名




书目名称Cardiovascular Biomarkers网络公开度




书目名称Cardiovascular Biomarkers网络公开度学科排名




书目名称Cardiovascular Biomarkers被引频次




书目名称Cardiovascular Biomarkers被引频次学科排名




书目名称Cardiovascular Biomarkers年度引用




书目名称Cardiovascular Biomarkers年度引用学科排名




书目名称Cardiovascular Biomarkers读者反馈




书目名称Cardiovascular Biomarkers读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:49:04 | 显示全部楼层
Contemporary Cardiologyhttp://image.papertrans.cn/c/image/221903.jpg
发表于 2025-3-22 03:33:15 | 显示全部楼层
https://doi.org/10.1007/978-1-59745-051-5cardiovascular; heart; heart disease; myocardial infarction; physiology; vascular disease
发表于 2025-3-22 07:14:18 | 显示全部楼层
Cardiovascular Biomarkers978-1-59745-051-5Series ISSN 2196-8969 Series E-ISSN 2196-8977
发表于 2025-3-22 11:30:03 | 显示全部楼层
A Summary of Observed Data and Pre-Amble, several clinical settings, increased cardiac troponin is associated with both short- and long-term adverse outcomes. In addition, mechanisms responsible for analytical false-positive cardiac troponin results are addressed.
发表于 2025-3-22 16:56:33 | 显示全部楼层
Impact on Science and Technology,te therapy that improves clinical outcome. Development and utilization of biomarkers has evolved substantially over the past three decades. The earliest biomarkers, such as alanine aminotransferase and lactate dehydrogenase, have fallen out of use with the development of moer sensitive and specific
发表于 2025-3-22 19:28:46 | 显示全部楼层
发表于 2025-3-22 23:02:51 | 显示全部楼层
https://doi.org/10.1007/978-3-7091-7622-1f three possible criteria: clinical symptoms compatible with AMI, typical electrocardiogram changes, and increases in markers of cardiac injury. However, because of the very good sensitivity and specificity of creatine kinase-MB (CK-MB), it eventually became rare to diagnose AMI in the absence of el
发表于 2025-3-23 05:24:32 | 显示全部楼层
The Light-Water-Moderated Reactor, diagnosis and risk stratification are needed so that early treatment can appropriately be administered to those at highest risk (.). Because ACS is a heterogeneous disease process, accomplishing these goals, especially in the patient without ST-elevation, can be challenging. The emergency departmen
发表于 2025-3-23 07:12:08 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-3 19:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表